Genomic landscape of the individual host response and outcomes in sepsis: A prospective cohort study

The Lancet Respiratory Medicine

Volumn 4, Issue 4, 2016, Pages 259-271

  Davenport, Emma E ^a   Burnham, Katie L ^a   Radhakrishnan, Jayachandran ^a   Humburg, Peter ^a   Hutton, Paula ^b   Mills, Tara C ^a   Rautanen, Anna ^a   Gordon, Anthony C ^c   Garrard, Christopher ^b   Hill, Adrian V S ^a   Hinds, Charles J ^d   Knight, Julian C ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

^d QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTOXIN; HLA ANTIGEN CLASS 2; HYPOXIA INDUCIBLE FACTOR 1ALPHA; MAMMALIAN TARGET OF RAPAMYCIN;

ADULT; ARTICLE; COHORT ANALYSIS; COMMUNITY ACQUIRED PNEUMONIA; FEMALE; GENE EXPRESSION; GENETIC VARIABILITY; GENOMICS; GLYCOLYSIS; HOST RESISTANCE; HUMAN; HUMAN CELL; HYPOXIA; IMMUNE RESPONSE; INTENSIVE CARE; LEUKOCYTE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUANTITATIVE TRAIT LOCUS; SEPSIS; T LYMPHOCYTE ACTIVATION; TRANSCRIPTOMICS; UNITED KINGDOM; AGED; COMMUNITY ACQUIRED INFECTION; COMPLICATION; GENE EXPRESSION PROFILING; GENETIC HETEROGENEITY; GENETIC VARIATION; GENETICS; IMMUNOLOGY; INTENSIVE CARE UNIT; MIDDLE AGED; PHENOTYPE; PNEUMONIA; REPRODUCIBILITY;

AGED; COMMUNITY-ACQUIRED INFECTIONS; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENETIC HETEROGENEITY; GENETIC VARIATION; GENOMICS; HUMANS; INTENSIVE CARE UNITS; LEUKOCYTES; MALE; MIDDLE AGED; PHENOTYPE; PNEUMONIA; PROSPECTIVE STUDIES; REPRODUCIBILITY OF RESULTS; SEPSIS;

EID: 84963568655     PISSN: 22132600     EISSN: 22132619     Source Type: Journal    
DOI: 10.1016/S2213-2600(16)00046-1     Document Type: Article

References (50)

1. Vincent JL, Opal SM, Marshall JC, Tracey KJ Sepsis definitions: time for change. Lancet 2013, 381:774-775.
2. Marshall JC Why have clinical trials in sepsis failed?. Trends Mol Med 2014, 20:195-203.
3. Cohen J, Vincent JL, Adhikari NK, et al. Sepsis: a roadmap for future research. Lancet Infect Dis 2015, 15:581-614.
4. Hotchkiss RS, Monneret G, Payen D Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy. Nat Rev Immunol 2013, 13:862-874.
5. Chapman SJ, Hill AV Human genetic susceptibility to infectious disease. Nat Rev Genet 2012, 13:175-188.
6. Rautanen A, Mills TC, Gordon AC, et al. Genome-wide association study of survival from sepsis due to pneumonia: an observational cohort study. Lancet Respir Med 2015, 3:53-60.
7. The Genotype-Tissue Expression (GTEx) pilot analysis: Multitissue gene regulation in humans. Science 2015, 348:648-660. GTEx Consortium.
8. Fairfax BP, Humburg P, Makino S, et al. Innate immune activity conditions the effect of regulatory variants upon monocyte gene expression. Science 2014, 343:1246949.
9. Knaus WA, Draper EA, Wagner DP, Zimmerman JE APACHE II: a severity of disease classification system. Crit Care Med 1985, 13:818-829.
10. Vincent JL, Moreno R, Takala J, et al. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med 1996, 22:707-710.
11. Kiiveri HT A general approach to simultaneous model fitting and variable elimination in response models for biological data with many more variables than observations. BMC Bioinformatics 2008, 9:195.
12. Arlot S, Celisse A A survey of cross-validation procedures for model selection. Stat Surv 2010, 4:40-79.
13. del Fresno C, Garcia-Rio F, Gomez-Pina V, et al. Potent phagocytic activity with impaired antigen presentation identifying lipopolysaccharide-tolerant human monocytes: demonstration in isolated monocytes from cystic fibrosis patients. J Immunol 2009, 182:6494-6507.
14. Pena OM, Pistolic J, Raj D, Fjell CD, Hancock RE Endotoxin tolerance represents a distinctive state of alternative polarization (M2) in human mononuclear cells. J Immunol 2011, 186:7243-7254.
15. Wu D, Lim E, Vaillant F, Asselin-Labat ML, Visvader JE, Smyth GK ROAST: rotation gene set tests for complex microarray experiments. Bioinformatics 2010, 26:2176-2182.
16. Biswas S, Storey JD, Akey JM Mapping gene expression quantitative trait loci by singular value decomposition and independent component analysis. BMC Bioinformatics 2008, 9:244.
17. Westra HJ, Peters MJ, Esko T, et al. Systematic identification of trans eQTLs as putative drivers of known disease associations. Nat Genet 2013, 45:1238-1243.
18. Saeed S, Quintin J, Kerstens HH, et al. Epigenetic programming of monocyte-to-macrophage differentiation and trained innate immunity. Science 2014, 345:1251086.
19. Fairfax BP, Makino S, Radhakrishnan J, et al. Genetics of gene expression in primary immune cells identifies cell type-specific master regulators and roles of HLA alleles. Nat Genet 2012, 44:502-510.
20. Bryois J, Buil A, Evans DM, et al. Cis and trans effects of human genomic variants on gene expression. PLoS Genet 2014, 10:e1004461.
21. Dimas AS, Deutsch S, Stranger BE, et al. Common regulatory variation impacts gene expression in a cell type-dependent manner. Science 2009, 325:1246-1250.
22. Hutchins NA, Unsinger J, Hotchkiss RS, Ayala A The new normal: immunomodulatory agents against sepsis immune suppression. Trends Mol Med 2014, 20:224-233.
23. Pachot A, Lepape A, Vey S, Bienvenu J, Mougin B, Monneret G Systemic transcriptional analysis in survivor and non-survivor septic shock patients: a preliminary study. Immunol Lett 2006, 106:63-71.
24. Tang BM, Huang SJ, McLean AS Genome-wide transcription profiling of human sepsis: a systematic review. Crit Care 2010, 14:R237.
25. Biswas SK, Lopez-Collazo E Endotoxin tolerance: new mechanisms, molecules and clinical significance. Trends Immunol 2009, 30:475-487.
26. Pena OM, Hancock DG, Lyle NH, et al. An Endotoxin Tolerance Signature Predicts Sepsis and Organ Dysfunction at Initial Clinical Presentation. EBioMedicine 2014, 1:64-71.
27. Pachot A, Monneret G, Brion A, et al. Messenger RNA expression of major histocompatibility complex class II genes in whole blood from septic shock patients. Crit Care Med 2005, 33:31-38.
28. Boomer JS, To K, Chang KC, et al. Immunosuppression in patients who die of sepsis and multiple organ failure. JAMA 2011, 306:2594-2605.
29. Falasca L, Farrace MG, Rinaldi A, Tuosto L, Melino G, Piacentini M Transglutaminase type II is involved in the pathogenesis of endotoxic shock. J Immunol 2008, 180:2616-2624.
30. Cai S, Lee CC, Kohwi-Shigematsu T SATB1 packages densely looped, transcriptionally active chromatin for coordinated expression of cytokine genes. Nat Genet 2006, 38:1278-1288.
31. Caliskan M, Baker SW, Gilad Y, Ober C Host genetic variation influences gene expression response to rhinovirus infection. PLoS Genet 2015, 11:e1005111.
32. Lill M, Koks S, Soomets U, et al. Peripheral blood RNA gene expression profiling in patients with bacterial meningitis. Front Neurosci 2013, 7:33.
33. Vanden Berghe T, Demon D, Bogaert P, et al. Simultaneous targeting of IL-1 and IL-18 is required for protection against inflammatory and septic shock. Am J Respir Crit Care Med 2014, 189:282-291.
34. Kirino Y, Bertsias G, Ishigatsubo Y, et al. Genome-wide association analysis identifies new susceptibility loci for Behcet's disease and epistasis between HLA-B*51 and ERAP1. Nat Genet 2013, 45:202-207.
35. He M, Horuk R, Moochhala SM, Bhatia M Treatment with BX471, a CC chemokine receptor 1 antagonist, attenuates systemic inflammatory response during sepsis. Am J Physiol Gastrointest Liver Physiol 2007, 292:G1173-G1180.
36. Venet F, Lepape A, Debard AL, Bienvenu J, Bohe J, Monneret G The Th2 response as monitored by CRTH2 or CCR3 expression is severely decreased during septic shock. Clin Immunol 2004, 113:278-284.
37. Arlt A, Schafer H Role of the immediate early response 3 (IER3) gene in cellular stress response, inflammation and tumorigenesis. Eur J Cell Biol 2011, 90:545-552.
38. Pham CT, Ley TJ Dipeptidyl peptidase I is required for the processing and activation of granzymes A and B in vivo. Proc Natl Acad Sci USA 1999, 96:8627-8632.
39. Brinkmann V, Reichard U, Goosmann C, et al. Neutrophil extracellular traps kill bacteria. Science 2004, 303:1532-1535.
40. Shalova IN, Lim JY, Chittezhath M, et al. Human monocytes undergo functional re-programming during sepsis mediated by hypoxia-inducible Factor-1α. Immunity 2015, 42:484-498.
41. Cheng SC, Quintin J, Cramer RA, et al. mTOR- and HIF-1alpha-mediated aerobic glycolysis as metabolic basis for trained immunity. Science 2014, 345:1250684.
42. Bakker J, Gris P, Coffernils M, Kahn RJ, Vincent JL Serial blood lactate levels can predict the development of multiple organ failure following septic shock. Am J Surg 1996, 171:221-226.
43. Takaoka Y, Goto S, Nakano T, et al. Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) prevents lipopolysaccharide (LPS)-induced, sepsis-related severe acute lung injury in mice. Sci Rep 2014, 4:5204.
44. Liu TF, Vachharajani V, Millet P, Bharadwaj MS, Molina AJ, McCall CE Sequential actions of SIRT1-RELB-SIRT3 coordinate nuclear-mitochondrial communication during immunometabolic adaptation to acute inflammation and sepsis. J Biol Chem 2015, 290:396-408.
45. Villar J, Ribeiro SP, Mullen JB, Kuliszewski M, Post M, Slutsky AS Induction of the heat shock response reduces mortality rate and organ damage in a sepsis-induced acute lung injury model. Crit Care Med 1994, 22:914-921.
46. Banton MC, Inder KL, Valk E, Rudd CE, Schneider H Rab8 binding to immune cell-specific adaptor LAX facilitates formation of trans-Golgi network-proximal CTLA-4 vesicles for surface expression. Mol Cell Biol 2014, 34:1486-1499.
47. Yang B, Wang J, Wang Y, et al. Novel function of Trim44 promotes an antiviral response by stabilizing VISA. J Immunol 2013, 190:3613-3619.
48. Ma Z, Moore R, Xu X, Barber GN DDX24 negatively regulates cytosolic RNA-mediated innate immune signaling. PLoS Pathog 2013, 9:e1003721.
49. Scicluna BP, Klein Klouwenberg PM, van Vught LA, et al. A molecular biomarker to diagnose community-acquired pneumonia on intensive care unit admission. Am J Respir Crit Care Med 2015, 192:826-835.
50. Wong HR, Cvijanovich NZ, Anas N, et al. Developing a clinically feasible personalized medicine approach to pediatric septic shock. Am J Respir Crit Care Med 2015, 191:309-315.